Hydroxychloroquine plus azithromycin early treatment of mild COVID-19 in an outpatient setting: a randomized, double-blinded, placebo-controlled clinical trial evaluating viral clearance
Autor: | Rodrigues, Cristhieni, Freitas-Santos, Rodrigo S., Levi, José Eduardo, Senerchia, Andreza A., Lopes, Ana Tarina A., Santos, Sergio R., Siciliano, Rinaldo F., Pierrotti, Lígia C. |
---|---|
Zdroj: | In International Journal of Antimicrobial Agents November 2021 58(5) |
Databáze: | ScienceDirect |
Externí odkaz: |